IMMUNE STUDIES IN RENAL-CELL CARCINOMA (RCC) PATIENTS TREATED WITH INTERFERON

被引：0
|
作者：
LESLIE, WT [1 ]
TAYLOR, SG [1 ]
HARRIS, JE [1 ]
BRAUN, DP [1 ]
机构：
[1] RUSH MED COLL,CHICAGO,IL 60612
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1986年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [31] PHASE I/II STUDY OF RECOMBINANT INTERFERON GAMMA (IMMUNERON TM) IN ADVANCED RENAL-CELL CARCINOMA (RCC)
    GARNICK, MB
    REICH, SD
    RICHIE, JP
    JOURNAL OF UROLOGY, 1986, 135 (04): : A166 - A166
  • [32] POLARIZED HELPER T-CELL RESPONSES TO RENAL-CELL CARCINOMA (RCC)
    SCHOOF, DD
    URBA, WJ
    WEINBERG, AD
    FASEB JOURNAL, 1995, 9 (04): : A1023 - A1023
  • [33] IMMUNE THERAPY OF ADVANCED RENAL-CELL CARCINOMA
    MANSECK, A
    WIRTH, M
    UROLOGE-AUSGABE A, 1993, 32 (05): : 360 - 373
  • [34] Inflammatory markers to predict prognosis in renal cell carcinoma (RCC) patients treated with immune checkpoint inhibitors (ICIs)
    Carril, Lucia
    De Liano Lista, Alfonso Gomez
    Pozas, Javier
    Gordoa, Teresa Alonso
    Bernardini, Alejandra
    Carretero-Gonzalez, Alberto
    Martin Soberon, Maria Cruz
    Sepulveda Sanchez, Juan Manuel Manuel
    Paramio, Jesus
    Castellano, Daniel
    De Velasco, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [35] Bevacizumab and interferon-α in metastatic renal-cell carcinoma
    Bukowski, Ronald M.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 253 - 254
  • [36] RECOMBINANT INTERFERON GAMMA IN METASTATIC RENAL-CELL CARCINOMA
    DOBERAUER, C
    LEBER, H
    SCHOMACHER, H
    AKTUELLE UROLOGIE, 1991, 22 (01) : 26 - 29
  • [37] INTERLEUKIN-2 AND INTERFERON IN RENAL-CELL CARCINOMA
    WERSALL, P
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (1-2): : 71 - 76
  • [38] INTERFERON AS ADJUNCTIVE TREATMENT FOR NONMETASTATIC RENAL-CELL CARCINOMA
    TAKAHASHI, S
    TANIGAWA, T
    IMAGAWA, M
    MIMATA, H
    NOMURA, Y
    OGATA, J
    BRITISH JOURNAL OF UROLOGY, 1994, 74 (01): : 11 - 14
  • [39] Bevacizumab and interferon-α in metastatic renal-cell carcinoma
    Ronald M. Bukowski
    Nature Reviews Clinical Oncology, 2009, 6 : 253 - 254
  • [40] EXPRESSION OF ACYLPEPTIDE HYDROLASE IS FREQUENTLY DECREASED IN RENAL-CELL CARCINOMA (RCC)
    ERLANDSSON, R
    ZABAROVSKY, ER
    ALLIKMETS, RL
    BOLDOG, F
    KASHUBA, VI
    KLEIN, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 453 - 453
12345